Previous studies have proposed several biomarkers for osteoporosis diagnosis, such as bone turnover markers, N-terminal propeptide of type I procollagen (PINP), and C-telopeptide of type I collagen (CTX-I), which can be used as auxiliary indices to evaluate drug response and treatment compliance in osteoporosis patients [73]. Here, COL1A2 is linked to osteoporosis.